HBT Financial, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HBT Financial, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $77.01M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $71.78M | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | $65.84M | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | $56.46M | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | $56.27M | Mar 6, 2024 |
| FY2022 | Dec 31, 2020 | $36.85M | Mar 8, 2023 |
| FY2021 | Dec 31, 2019 | $66.87M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $63.80M | Mar 12, 2021 |
| FY2019 | Dec 31, 2017 | $56.10M | Mar 27, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $85.07M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $89.37M | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | $65.83M | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | $72.59M | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | $43.02M | Mar 6, 2024 |
| FY2022 | Dec 31, 2020 | $31.26M | Mar 8, 2023 |
| FY2021 | Dec 31, 2019 | $89.09M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $79.99M | Mar 12, 2021 |
| FY2019 | Dec 31, 2017 | $72.08M | Mar 27, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.07B | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $5.03B | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $5.07B | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $4.29B | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $4.31B | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $3.67B | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $3.25B | Mar 12, 2021 |
| FY2019 | Dec 31, 2018 | $3.25B | Mar 27, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.46B | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $4.49B | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $4.58B | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $3.91B | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $3.90B | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $3.30B | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $2.91B | Mar 12, 2021 |
| FY2019 | Dec 31, 2018 | $2.91B | Mar 27, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $615.50M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $544.61M | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | $489.50M | Mar 6, 2026 |
| FY2025 | Dec 31, 2022 | $373.63M | Mar 6, 2026 |
| FY2024 | Dec 31, 2021 | $411.88M | Mar 7, 2025 |
| FY2023 | Dec 31, 2020 | $363.92M | Mar 6, 2024 |
| FY2022 | Dec 31, 2019 | $332.92M | Mar 8, 2023 |
| FY2021 | Dec 31, 2018 | $340.40M | Mar 11, 2022 |
| FY2020 | Dec 31, 2017 | $323.92M | Mar 12, 2021 |
| FY2019 | Dec 31, 2016 | $326.25M | Mar 27, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $59.82M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $59.82M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $59.82M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $29.32M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $29.32M | Mar 8, 2023 |
| FY2022 | Dec 31, 2020 | $23.62M | Mar 8, 2023 |
| FY2022 | Dec 31, 2019 | $23.62M | Mar 8, 2023 |
| FY2021 | Dec 31, 2018 | $23.62M | Mar 11, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $367.16M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $316.76M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $269.05M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $232.00M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $194.13M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $154.61M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $134.29M | Mar 12, 2021 |
| FY2019 | Dec 31, 2018 | $315.23M | Mar 27, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $122.27M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $137.69M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $141.25M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $114.16M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $409.27M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $312.45M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $283.97M | Mar 12, 2021 |
| FY2019 | Dec 31, 2018 | $186.88M | Mar 27, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Mar 6, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Mar 8, 2023 |
| FY2021 | Dec 31, 2019 | 3 | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | 3 | Mar 12, 2021 |
| FY2019 | Dec 31, 2017 | 3 | Mar 27, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Mar 6, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Mar 8, 2023 |
| FY2021 | Dec 31, 2019 | 3 | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | 3 | Mar 12, 2021 |
| FY2019 | Dec 31, 2017 | 3 | Mar 27, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 31.43M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | 31.56M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | 31.70M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | 28.75M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | 28.99M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | 27.46M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | 27.46M | Mar 12, 2021 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.61M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $24.18M | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | $21.87M | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | $18.58M | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | $16.75M | Mar 6, 2024 |
| FY2022 | Dec 31, 2020 | $16.52M | Mar 8, 2023 |
| FY2021 | Dec 31, 2019 | $224.96M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $42.62M | Mar 12, 2021 |
| FY2019 | Dec 31, 2017 | $57.07M | Mar 27, 2020 |